Cargando…
1238. The Novel Semisynthetic Saponin Adjuvant TQL1055 Enhances the Antibody Response to Pertussis Vaccine with an Improved Tolerability Profile over QS-21
BACKGROUND: Acellular pertussis vaccines are better tolerated but less immunogenic than older whole cell vaccines. Novel adjuvants may be useful to enhance their immunogenicity. First-generation natural saponins are potent immuno-enhancers but are highly reactogenic. The novel semisynthetic saponin...
Autores principales: | Buzz, Chloe, Ragupathi, Govind, Bennett, Sean R, Livingston, Phil, Farris, Eric, Martin, Tyler |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777340/ http://dx.doi.org/10.1093/ofid/ofaa439.1423 |
Ejemplares similares
-
1237. Robust Adjuvant Activity and Dose-sparing Potential of the Novel Semisynthetic Saponin Adjuvant TQL1055 for Seasonal and Pandemic Influenza
por: Buzz, Chloe, et al.
Publicado: (2020) -
1045. Safety of the Synthetic Saponin Adjuvant TQL1055: Preliminary Results from a First-in-humans Trial
por: Bennett, Sean R, et al.
Publicado: (2021) -
Development of a minimal saponin vaccine adjuvant based on QS-21
por: Fernández-Tejada, Alberto, et al.
Publicado: (2014) -
Quality Assurance: from quality control to TQM/TQL
por: CERN. Geneva. Audiovisual Unit
Publicado: (2000) -
Atomic Model and Micelle Dynamics of QS-21 Saponin
por: Pedebos, Conrado, et al.
Publicado: (2014)